Rudy Schreiber
Overview
Explore the profile of Rudy Schreiber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veggel L, Voets A, Vanmierlo T, Schreiber R
Neural Regen Res
. 2024 Aug;
20(6):1717-1718.
PMID: 39104109
No abstract available.
2.
Veggel L, Mocking T, Sijben H, Liu R, Gorostiola Gonzalez M, Dilweg M, et al.
ACS Chem Neurosci
. 2024 Mar;
15(7):1424-1431.
PMID: 38478848
Excitatory amino acid transporters (EAATs) are important regulators of amino acid transport and in particular glutamate. Recently, more interest has arisen in these transporters in the context of neurodegenerative diseases....
3.
Huisman G, Menke M, Grundmann O, Schreiber R, Mason N
Int J Environ Res Public Health
. 2023 Jul;
20(14).
PMID: 37510657
Kratom () is a Southeast Asian plant containing various alkaloids that induce pharmacological effects in humans. In Western countries, online vendors sell a variety of different kratom strains which are...
4.
van Zalm P, Ahmed S, Fatou B, Schreiber R, Barnaby O, Boxer A, et al.
Cell Rep Med
. 2023 Apr;
4(4):101005.
PMID: 37075703
To develop therapies for Alzheimer's disease, we need accurate in vivo diagnostics. Multiple proteomic studies mapping biomarker candidates in cerebrospinal fluid (CSF) resulted in little overlap. To overcome this shortcoming,...
5.
Klaas S, Barbut Siva J, Bak M, Govers M, Schreiber R
Biomed Pharmacother
. 2023 Mar;
161:114166.
PMID: 36898260
Background: Although Post-SSRI Sexual Dysfunction (PSSD) has finally been recognized by the European Medicines Agency as a medical condition that can outlast discontinuation of SSRI and SNRI antidepressants, this condition...
6.
Kong L, He Q, Li Q, Schreiber R, Kaitin K, Shao L
Drug Discov Today
. 2023 Jan;
28(3):103485.
PMID: 36623797
Central nervous system (CNS) drug discovery suffers from high attrition rates; translational neuroscience approaches aiming to reduce these high rates include the use of brain imaging technologies. However, there is...
7.
Upadhyay J, Verrico C, Cay M, Kodele S, Yammine L, Koob G, et al.
Lancet Psychiatry
. 2022 Jul;
9(8):e37-e38.
PMID: 35843258
No abstract available.
8.
Schreiber R, Campbell U, Quinton M, Hardy L, Fang Q, Lew R
Biomed Pharmacother
. 2022 Jul;
153:113359.
PMID: 35785702
Inhibitors of dopamine transporters (DAT), norepinephrine transporters (NET) and serotonin transporters (SERT) are effective treatments for neuropsychiatric diseases. Dasotraline [(1R,4 S)- 4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydro-1-naphthalenamine, also known as SEP-225289) was evaluated for...
9.
van den Berg M, Magaraggia I, Schreiber R, Hillhouse T, Porter J
Psychopharmacology (Berl)
. 2022 Mar;
239(6):1853-1879.
PMID: 35348806
Rationale: Recent trials with psychedelics in major depressive disorder and treatment-resistant depression showed remarkable improvements in depressive symptoms that can last for up to several months after even a single...
10.
van Hagen B, van Goethem N, Nelissen E, Paes D, Koymans K, van Hoof S, et al.
Mol Cell Neurosci
. 2022 Mar;
120:103719.
PMID: 35283305
Pattern separation is a hippocampal process in which highly similar stimuli are recognized as separate representations, and deficits could lead to memory impairments in neuropsychiatric disorders such as schizophrenia. The...